Evidence map›Paper›PMID 37808574›Full record

ArticleClinical case reports2023

Acute toxic effects of areca nut on central nervous system and liver: A case report.

Seyede Maryam Mahdavi Mortazavi, Maryam Ataollahi, Amirali Mashhadiagha, Seyed Ali Moosavi, Reze Moshfeghinia, Marzieh Soheili

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Seyede Maryam Mahdavi MortazaviDepartment of Pediatrics, School of Medicine, Namazi Teaching Hospital Shiraz University of Medical Sciences Shiraz Iran.
Maryam AtaollahiDepartment of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina Center for Medicine & Organ Transplant Shiraz University of Medical Sciences Shiraz Iran.
Amirali MashhadiaghaStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-8953-8979
Seyed Ali MoosaviStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.
Reze MoshfeghiniaStudent Research Committee Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0001-6642-6803
Marzieh SoheiliCollege of Pharmacy and Health Sciences Western New England University Springfield Massachusetts USA.
Shiraz University of Medical Sciences · IRWestern New England University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Areca nut (AN) is an addictive substance widely used in different world regions. There are several side effects associated with the use of AN, which have already been reported. However, the reports on hepatotoxicity of AN are sporadic and non-conclusive. In the present case report, we investigated the hepatotoxicity of AN in a four-year-old Iranian girl who was transferred to our medical center with abdominal pain, vomiting, diarrhea, fever, and other symptoms such as hematuria, decreased mental status, multiple seizure episodes. After a comprehensive evaluation, it was concluded that these signs and symptoms were all attributed to AN consumption, which was given by her mother to control diarrhea. Eventually, the patient medical conditions were managed successfully, and she survived by intense medical care. In conclusion, we suggest AN should be considered a potential hepatotoxic agent.

Indexed as

an addictive substanceAreca nutcase reporthepatotoxic agenthepatotoxicity

Identifiers

PMID37808574
PMCPMC10551103
OpenAlexW4387371745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.